You have 9 free searches left this month | for more free features.

Chronic Lymphocytic Leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Jul 19, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Questionnaires
    • Fit Bit
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 20, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 19, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Understanding Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Aug 1, 2022

        Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Leukemia
        • Boston, Massachusetts
        • +1 more
        Nov 14, 2022

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Pneumococcal 13-valent Conjugate Vaccine
        • Pneumococcal Polyvalent Vaccine
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 10, 2022

        Chronic Lymphocytic Leukemia Trial in Salt Lake City (Nicotinamide, Placebo)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Salt Lake City, Utah
          Huntsman Cancer Institute at University of Utah
        Jan 17, 2023

        Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

        Active, not recruiting
        • Recurrent Chronic Lymphocytic Leukemia
        • +3 more
        • Duarte, California
        • +2 more
        Oct 7, 2022